The previous evidence indicated that high PKM2 expression was significantly associated with lymph node metastasis and distant metastasis, as well as poor prognosis in LUAD (Sun et al., 2015). This evidence concerns the gene PKM and metastatic malignant neoplasm in the lymph nodes.